Monteris Medical
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Monteris Medical sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Monteris Medical: 8 sponsored US clinical trials, 1 recruiting.
Monteris Medical sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Radiation Necrosis, with 2 trials.
Upper-quartile sponsor footprint
Monteris Medical sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
REMASTer: REcurrent Brain Metastases After SRS Trial
NCT05124912
PatiEnt Neuropsychological outcomeS After laseR Ablation
NCT05075850
Feasibility Study on LITT for Newly Diagnosed Glioblastoma
NCT02880410
Feasibility Study on LITT for Medical Refractory Epilepsy
NCT02820740
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
NCT02392078
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
NCT02389855
Laser Ablation After Stereotactic Radiosurgery
NCT01651078
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
NCT00747253
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Therapeutic Areas
What is open in the Monteris Medical pipeline
1 recruiting of 8 indexed (13% open); 5 completed (63%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Radiation Necrosis (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Monteris Medical: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Monteris Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this Monteris Medical page
8 registered trials is a research-attention snapshot, not an endorsement of Monteris Medical or any single study.
- 1 of Monteris Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Radiation Necrosis is the condition Monteris Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Radiation Necrosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Monteris Medical pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.